A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial

A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial

Abstract Background Older patients with type 2 diabetes mellitus (T2D) have an increased risk of hypoglycaemic episodes when using sulphonylureas or insulin. In the Netherlands, guidelines exist for reducing glucose-lowering medication in older patients. However, evidence is lacking that a medicatio...

Full description

Bibliographic Details
Main Authors: Charlotte Andriessen, Marieke T. Blom, Beryl A. C. E. van Hoek, Anna W. de Boer, Petra Denig, G. Ardine de Wit, Karin Swart, Angela de Rooij-Peek, Rob J. van Marum, Jacqueline G. Hugtenburg, Pauline Slottje, Daniël van Raalte, Liselotte van Bloemendaal, Ron Herings, Giel Nijpels, Rimke C. Vos, Petra J. M. Elders
Format: Article
Language:English
Published: BMC 2024-07-01
Series:Trials
Subjects:
Elderly
Type 2 diabetes
Overtreatment
Hypoglycaemia
General practitioners
Extended normalisation process theory
Online Access:https://doi.org/10.1186/s13063-024-08249-9

Internet

https://doi.org/10.1186/s13063-024-08249-9

Similar Items